|Vertex Pharmaceuticals Incorporated -- USA Stock|| |
USD 157.89 8.01 4.83%
Senior Vice President Corporate Controller
Mr. Paul M. Silva is Senior Vice President and Corporationrationrate Controller of Vertex Pharmaceuticals Incorporated. Mr. Silva is our Senior Vice President and Corporationrationrate Controller, a position he has held since April 2011. Mr. Silva joined us in August 2007 as Senior Director, Accounting Operations and was our Vice President and Corporationrationrate Controller from September 2008 through April 2011. Prior to joining us, he was the Vice President, Internal Reporting at Iron Mountain Incorporated from July 2006 until August 2007 and a consultant to Iron Mountains financing department from April 2005 until July 2006. He was the Finance Director of the Bioscience Technologies Division of Thermo Electron Corporationrationration from 2002 to April 2005
Age: 50 President Since 2011
Silva holds a B.S. in accounting from Assumption College.
Paul Silva Latest Insider Activity
The company has return on total asset (ROA)
of 10.73 %
which means that it generated profit of $10.73 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE)
of 5.42 %
meaning that it created $5.42 on every $100 dollars invested by stockholders.
The company currently holds 606.43 M in liabilities with Debt to Equity (D/E) ratio of 29.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vertex Pharmaceuticals Incorporated has Current Ratio of 3.21 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Vertex Pharmaceuticals Incorporated, a biotechnology company, develops medicines for serious diseases. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and traded on NASDAQ exchange. It employs 2300 people.Vertex Pharmaceuticals Incorporated (VRTX) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 2,300 people. Vertex Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.